Patent · US Active

BACE1 inhibitors

US10047081B2 · kind B2 · utility

3Cited by

0References

25Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bjoern Bartels · Schopfheim, DE
Cosimo Dolente · Allschwil, CH
Wolfgang Guba · Memmingen, DE
Wolfgang Haap · Bad Kötzting, DE
Ulrike Obst Sander · Sursee, CH
Jens-Uwe Peters · Weil am Rhein, DE
Thomas Woltering · Freiburg (Elbe), DE

Key dates

Filing date	Mar 16, 2016
Grant date	Aug 14, 2018
Priority date	—
Expiry date	Mar 16, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula I, having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.